Mounjaro in the news

31st January 2025 – Half the public support the use of weight loss drugs to treat obesity (APNORC)

25th January 2025 – Gemma Collins shares transformation after weight loss treatment (Daily Mail)

21st January 2025 – Mounjaro shows “decrease in risk of Alzheimer’s” (Fierce Pharma)

20th January 2025 – Weight-loss jabs linked to reduced risk of 42 conditions including dementia (The Guardian)

14th January 2025 – Call for overhaul to obesity diagnosis (The Guardian)

13th January 2025 – Prescribing to all 3.4million eligible patients would cost £10bn a year (Daily Mail)

9th January 2025 – UK obesity rates may start dropping th25th January 2025 – Gemma Collins is year because of weight loss jabs (Independent)

7th January 2025 – Mounjaro manufacturer sponsors the Golden Globes (MSN)

6th January 2025 – GLP-1 drugs may be the jack of all trades (The Courier)

4th January 2025 – Mounjaro has been launched in China (FirstWord Pharma)

2nd January 2025 – GLP-1 drugs may offer health benefits beyond weight loss (People)

1st January 2025 – Weight loss drugs cut food spending (AgriPulse)

26th December 2024 – Elon Musk reveals he’s taking Mounjaro (NY Post)

21st December 2024 – 500k buying weight loss jabs online because of slow NHS rollout (Telegraph)

19th December 2024 – “Superior weight loss”: Mounjaro squashing rival Wegovy (Chemist & Druggist)

15th December 2024 – EMA says now new approval needed for Mounjaro for Sleep Apnea (Sleep Review)

11th December 2024 – NICE recommends Mounjaro for overweight and obesity (Pharmafile)

7th December 2024 – Mounjaro will be available in Ireland early next year (Irish Independent)

6th December 2024 – Weight loss drug will help “so many”, say users (BBC)

5th December 2024 – obese people will have to wait for weight loss jab Mounjaro, NHS officials warn (Independent)

4th December 2024 – rise of dangerous weight loss black market sparks concern (Diabetes UK)

3rd December 2024 – Social drinkers on obesity drugs lose the taste for alcohol (NPR)

27th November 2024 – Biden proposes expanded Medicare to cover obesity drugs (Reuters)

23rd November 2024 – Whoopi Goldberg’s Mounjaro weight loss journey (The Daily Mail)

19th November 2024 – 24% of Brits would take weight-loss jabs for free on NHS (Independent)

19th November 2024 – Mounjaro shows cardiovascular benefits in patients with obesity (Yahoo)

16th November 2024 – Mounjaro now available in Belgium (Brussels Times)

15th November 2024 – 99% of Mounjaro patients remain diabetes-free after 3 years (Reuters)

13th November 2024 – Mounjaro lowers Type 2 diabetes risk in phase 3 trial (New England Journal of Medicine)

13th November 2024 – GPhC looked into 2 online pharmacies after Tik Tok influencer concerns (Chemist & Druggist)

12th November 2024 – warnings over fake Ozempic & Mounjaro being sold online (South Africa)

11th November 2024 – Mounjaro praised as “super GLP-1 RA” (Korea Biomedical Review)

10th November 2024 – Hong Kong approves “celebrity weight loss drug” (South China Morning Post)

9th November 2024 – approved weight loss drug contributed to nurse’s death (The Guardian)

28th October 2024 – Mounjaro set to be approved for use in Hong Kong by the end of 2024.

28th October 2024 – Study finds Zepbound and Mounjaro more effective for weight loss than Wegovy and Ozempic, via the Journal of the American Medical Association (JAMA)

27th October 2024 – Mounjaro manufacturer Eli Lilly to invest $5 billion to increase production capacity for Tirzepatide, the active ingredient in Mounjaro.

27th October 2024 – Weight Loss Surgeries declined by 25% in the USA between 2022 and 2023 as more patients turn to GLP-1 weight loss treatments like Mounjaro, via JAMA.

26th October 2024 – Mounjaro to launch in Denmark next week.

15th October 2024 – Health Innovation Manchester to run 5 year real-world study to measure the impact of Mounjaro on job prospects (via BBC).

2nd October 2024 – FDA removes Mounjaro from the official US medications shortage list (via FDA).